Cardinal Health (CAH) Competitors $118.28 +1.28 (+1.09%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CAH vs. MCK, COR, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDSShould you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include McKesson (MCK), Cencora (COR), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS). Cardinal Health vs. McKesson Cencora Henry Schein Patterson Companies Owens & Minor Herbalife Nu Skin Enterprises Cosmos Health HWH International TRxADE HEALTH Cardinal Health (NYSE:CAH) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, community ranking, risk and valuation. Which has more risk & volatility, CAH or MCK? Cardinal Health has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Which has better earnings and valuation, CAH or MCK? McKesson has higher revenue and earnings than Cardinal Health. Cardinal Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardinal Health$224.45B0.13$852M$5.1423.01McKesson$330.19B0.22$3.00B$19.3130.02 Is CAH or MCK more profitable? McKesson has a net margin of 0.77% compared to Cardinal Health's net margin of 0.56%. Cardinal Health's return on equity of -56.56% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Cardinal Health0.56% -56.56% 4.13% McKesson 0.77%-207.50%5.45% Does the MarketBeat Community prefer CAH or MCK? McKesson received 51 more outperform votes than Cardinal Health when rated by MarketBeat users. Likewise, 74.23% of users gave McKesson an outperform vote while only 71.64% of users gave Cardinal Health an outperform vote. CompanyUnderperformOutperformCardinal HealthOutperform Votes91771.64% Underperform Votes36328.36% McKessonOutperform Votes96874.23% Underperform Votes33625.77% Does the media refer more to CAH or MCK? In the previous week, Cardinal Health had 6 more articles in the media than McKesson. MarketBeat recorded 18 mentions for Cardinal Health and 12 mentions for McKesson. Cardinal Health's average media sentiment score of 0.93 beat McKesson's score of 0.90 indicating that Cardinal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 9 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of CAH or MCK? 87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate CAH or MCK? Cardinal Health currently has a consensus price target of $127.50, indicating a potential upside of 7.80%. McKesson has a consensus price target of $650.14, indicating a potential upside of 12.14%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than Cardinal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62McKesson 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.94 Is CAH or MCK a better dividend stock? Cardinal Health pays an annual dividend of $2.02 per share and has a dividend yield of 1.7%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cardinal Health pays out 39.3% of its earnings in the form of a dividend. McKesson pays out 14.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years. SummaryMcKesson beats Cardinal Health on 16 of the 22 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Cardinal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAH vs. The Competition Export to ExcelMetricCardinal HealthDrugs, proprietaries, & sundries IndustryMedical SectorNYSE ExchangeMarket Cap$28.62B$19.76B$5.12B$19.18BDividend Yield1.75%1.47%4.91%3.59%P/E Ratio23.0110.7691.3441.28Price / Sales0.138.901,116.5917.59Price / Cash11.1512.2742.6421.28Price / Book-8.9713.334.795.32Net Income$852M$862.89M$120.07M$989.88M7 Day Performance0.15%-6.95%-1.89%-3.54%1 Month Performance-4.07%-10.66%11.45%-3.68%1 Year Performance16.85%-6.09%30.61%12.14% Cardinal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAHCardinal Health4.7219 of 5 stars$118.28+1.1%$127.50+7.8%+19.3%$28.62B$224.45B23.0148,900Analyst ForecastHigh Trading VolumeMCKMcKesson4.9558 of 5 stars$575.01-0.2%$643.43+11.9%+30.0%$72.99B$330.19B29.8451,000Analyst ForecastCORCencora4.7201 of 5 stars$230.94-0.6%$275.60+19.3%+14.0%$44.64B$638.56M30.9246,000HSICHenry Schein3.9527 of 5 stars$76.42-0.2%$78.89+3.2%-4.9%$9.53B$12.34B31.5225,000PDCOPatterson Companies4.1391 of 5 stars$31.02-0.2%$26.24-15.4%+11.0%$2.74B$6.57B18.187,600Analyst ForecastOMIOwens & Minor4.5636 of 5 stars$13.71-1.6%$18.50+34.9%-38.1%$1.06B$10.33B0.0013,700Positive NewsHLFHerbalife4.6776 of 5 stars$7.23-3.3%$9.90+36.9%-56.6%$728.73M$5.00B8.669,200NUSNu Skin Enterprises3.55 of 5 stars$7.33-2.1%$8.88+21.1%-65.8%$364.38M$1.78B-3.593,700Analyst ForecastAnalyst RevisionGap DownCOSMCosmos Health0.3524 of 5 stars$0.70-3.0%N/A-54.5%$16.28M$53.38M-0.29123Gap UpHWHHWH InternationalN/A$0.56-16.6%N/AN/A$15.06MN/A0.00N/ANews CoverageGap UpMEDSTRxADE HEALTHN/A$7.47-4.5%N/A+54.9%$10.50M$7.45M0.0050Gap Down Related Companies and Tools Related Companies McKesson Competitors Cencora Competitors Henry Schein Competitors Patterson Companies Competitors Owens & Minor Competitors Herbalife Competitors Nu Skin Enterprises Competitors Cosmos Health Competitors HWH International Competitors TRxADE HEALTH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CAH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.